PS
GILD icon

Principal Securities’s Gilead Sciences GILD Stock Holding History

Principal Securities’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.08M Buy
29,286
+4,337
+17% +$607K 0.06% 307
2025
Q4 		$3.06M Buy
24,949
+4,615
+23% +$561K 0.05% 342
2025
Q3 		$2.26M Buy
20,334
+1,094
+6% +$124K 0.04% 415
2025
Q2 		$2.13M Buy
19,240
+4,802
+33% +$511K 0.04% 391
2025
Q1 		$1.33M Buy
14,438
+34
+0.2% +$3.51K 0.03% 462
2024
Q4 		$1.33M Buy
14,404
+4,468
+45% +$402K 0.03% 462
2024
Q3 		$833K Buy
9,936
+1,722
+21% +$131K 0.02% 589
2024
Q2 		$564K Buy
8,214
+1,262
+18% +$84.2K 0.02% 662
2024
Q1 		$509K Buy
6,952
+25
+0.4% +$1.92K 0.02% 658
2023
Q4 		$561K Buy
+6,927
New +$539K 0.02% 555

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Principal Securities's GILD Position: Q1 2026 in Review

Principal Securities increased its Gilead Sciences (GILD) stake by 17% in Q1 2026, buying an estimated $607K and bringing the position to 29,286 shares worth $4.08M. The position accounts for 0.06% of the portfolio, ranked #307.

Principal Securities first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Principal Securities held 29,286 shares of Gilead Sciences worth $4.08M as of Q1 2026.
  • Principal Securities bought 4,337 Gilead Sciences shares in Q1 2026, an estimated $607K.
  • Gilead Sciences made up 0.06% of Principal Securities's portfolio in Q1 2026, its #307 holding.
  • Principal Securities first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Principal Securities's 13F filing for Q1 2026, filed 13 May 2026.